All Events

Dan Coatsworth is a Stock Market Analyst at AJ Bell and co-host of the Money & Markets podcast. He has written about investing for the past 18 years and his work has appeared in many of the UK's leading newspapers, websites and magazines.

Mr Tsvetkov has over 25 years of financial, accounting and operational experience, including significant experience of working with promoter/founder-led energy sector listed companies in London, Africa, Asia and Canada. Mr Tsvetkov was Chief Financial Officer of OPG Power Generation Pvt Ltd, the Chennai subsidiary of OPG from July 2017 to October 2017.He has a Chartered Accountant (CA) designation from the Canadian Institute of Chartered Accountants, an FCCA designation from the Association of Chartered and Certified Accountants in the UK and Chartered Financial Analyst (CFA) designation from the CFA Institute in the US.

José Luis, founder and CEO of Mirada, is a broadly recognised professional with almost 20 years of experience in the Telecommunications industry. Chairman of AEDETI, José Luis holds a degree in both Advanced Telecommunication Engineering (UPM) and an MBA from IESE Business School. He is a regular conference speaker and is considered one of the most important personalities in the Spanish digital TV industry.

In 2003, Neil became CEO and founding partner of Inspiration Healthcare Limited, leading them through the reverse acquisition of Inditherm plc and onto AIM in June 2015. Neil has spent 28 years in the Medical Device sector. Neil held a Non-executive Director position of Neuroprotexeon Limited, a drug-discovery and biotechnology company, in which the Group is a shareholder.

Key Areas of Expertise Medical device market, market development, product development, regulatory affairs, strategic planning.

Stephen qualified as a Chartered Accountant in 1981.He was appointed as the MD of Bleckmann (UK) Frans Maas, a listed Dutch logistics and freight forwarding company, in 1984. He set up Delamode in the UK in 1988. Stephen also has experience across a broad range of business activities including menswear shops, safe servicing company, garment production and commercial property development.

Stuart qualified as a chartered accountant with Deloitte in 1999. He joined Xpediator as Chief Finance Officer in September 2018 with a vast range of experience within the financial services and private equity sectors. Stuart was previously Chief Executive of Dollar UK, the alternative financial services provider, with prior experience as Chief Operating Officer of Listed Products at Harbourvest Partners and 3i where he was variously Chief Operating Officer of Asia and Americas, Chief Financial Officer of Infrastructure and Finance and Operations Director of Quoted Private Equity.

Faisal is a founder shareholder of Synnovia and Director of the Company. He has worked for and with manufacturing companies for over 20 of the last 30 years. He spent 7 years working in private equity with Capricorn Ventures International and prior to that was a partner at Deloitte & Touche, and was a managing director of a specialist consulting subsidiary of Deloitte & Touche. He is a graduate of Oxford University and has an MBA from Harvard Business School. Faisal was also chairman of Broker Network Holdings plc, an AIM listed company.

Steven Frazer is Shares' online editor and technology writer, covering all the big tech themes from big data to mobile, microprocessors to new energy, with an investment slant. He's been writing about technology, business, investment and markets for 15 years and his off-diary stories, deeper think features and daily Tweets often move share prices.  Find him at the Shares magazine website (www.sharesmagazine.co.uk) or tweeting at @SharesMagSteve.

Denis Taschuk has 30+ years of experience in corporate strategy development, manufacturing, market development and finance. Prior to Radient, Mr. Taschuk was a Partner and CEO of JAG Flocomponents LP, where he oversaw the expansion of the Company into international markets. Mr. Taschuk is also a Director of Tyhee Gold Corp. (TDC: TSX.V) and was previously a Director of the International Diabetes Federation. He is a Chartered Accountant and holds a Bachelor of Commerce Degree from the University of Alberta.

As CEO of Diaceutics, Peter Keeling’s role with the company complements over thirty years’ experience in international healthcare which began at GSK and Diagnology. He has operated and led companies and teams in the US, Europe, Asia and BRIC countries, inspiring product innovation and global launches while repeatedly delivering high corporate value growth for shareholders. Widely published in peer reviewed economic and precision medicine journals; Peter is a seasoned speaker and is considered one of the world’s thought leaders in the diagnostic commercialization industry.

Mark is CEO of Mercia Technologies PLC, having led the flotation in December 2014 and before that the management buyout of its precursor Mercia Fund Management in 2010. Latterly he led the acquisition in 2016 of Enterprise Ventures. Mark chairs the executive committee and the boards of Mercia’s wholly owned fund management businesses (Mercia Fund Management, Enterprise Ventures and EV Business Loans). In addition he sits on the board of portfolio company Oxford Genetics and has portfolio responsibility for PsiOxus Therapeutics.